Movatterモバイル変換


[0]ホーム

URL:


AU6361294A - Taxol-based compositions with enhanced bioactivity - Google Patents

Taxol-based compositions with enhanced bioactivity

Info

Publication number
AU6361294A
AU6361294AAU63612/94AAU6361294AAU6361294AAU 6361294 AAU6361294 AAU 6361294AAU 63612/94 AAU63612/94 AAU 63612/94AAU 6361294 AAU6361294 AAU 6361294AAU 6361294 AAU6361294 AAU 6361294A
Authority
AU
Australia
Prior art keywords
taxol
based compositions
enhanced bioactivity
bioactivity
enhanced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63612/94A
Inventor
Richard B Greenwald
Robert G.L. Shorr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzon Pharmaceuticals Inc
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon IncfiledCriticalEnzon Inc
Publication of AU6361294ApublicationCriticalpatent/AU6361294A/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU63612/94A1993-03-091994-03-08Taxol-based compositions with enhanced bioactivityAbandonedAU6361294A (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US2874393A1993-03-091993-03-09
US0287431993-03-09
PCT/US1994/002441WO1994020089A1 (en)1993-03-091994-03-08Taxol-based compositions with enhanced bioactivity

Publications (1)

Publication NumberPublication Date
AU6361294Atrue AU6361294A (en)1994-09-26

Family

ID=21845171

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU63612/94AAbandonedAU6361294A (en)1993-03-091994-03-08Taxol-based compositions with enhanced bioactivity

Country Status (2)

CountryLink
AU (1)AU6361294A (en)
WO (1)WO1994020089A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU730244B2 (en)*1996-08-202001-03-01Enzon, Inc.High molecular weight polymer-based prodrugs

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5886026A (en)*1993-07-191999-03-23Angiotech Pharmaceuticals Inc.Anti-angiogenic compositions and methods of use
US5880131A (en)*1993-10-201999-03-09Enzon, Inc.High molecular weight polymer-based prodrugs
US5622986A (en)*1993-10-201997-04-22Enzon, Inc.2'-and/or 7-substituted taxanes
GB9405400D0 (en)*1994-03-181994-05-04Erba Carlo SpaTaxane derivatives
CA2178541C (en)1995-06-072009-11-24Neal E. FearnotImplantable medical device
CA2250295C (en)*1996-03-122008-12-30Pg-Txl Company L.P.Water soluble paclitaxel prodrugs
US6576636B2 (en)1996-05-222003-06-10Protarga, Inc.Method of treating a liver disorder with fatty acid-antiviral agent conjugates
WO2002072150A2 (en)2001-03-132002-09-19Angiotech Pharmaceuticals Inc.Micellar drug delivery vehicles and uses thereof
AU2002303164A1 (en)*2001-03-232002-10-08Protarga, Inc.Fatty amine drug conjugates
DK1392254T3 (en)2001-04-202007-07-02Univ British Columbia Micelle drug delivery system for hydrophobic drugs
DE60331367D1 (en)2002-12-302010-04-01Angiotech Int Ag ACTIVE COMPOSITION OF FAST GELING POLYMERIC COMPOSITION
US7989490B2 (en)2004-06-022011-08-02Cordis CorporationInjectable formulations of taxanes for cad treatment
US8003122B2 (en)2004-03-312011-08-23Cordis CorporationDevice for local and/or regional delivery employing liquid formulations of therapeutic agents
US7846940B2 (en)2004-03-312010-12-07Cordis CorporationSolution formulations of sirolimus and its analogs for CAD treatment
EP2380606B1 (en)2006-06-302018-03-21Cook Medical Technologies LLCMethods of manufacturing and modifying taxane coatings for implantable medical devices
US8409601B2 (en)2008-03-312013-04-02Cordis CorporationRapamycin coated expandable devices
US8420110B2 (en)2008-03-312013-04-16Cordis CorporationDrug coated expandable devices
US8273404B2 (en)2008-05-192012-09-25Cordis CorporationExtraction of solvents from drug containing polymer reservoirs
US8642063B2 (en)2008-08-222014-02-04Cook Medical Technologies LlcImplantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120303115A1 (en)2011-05-252012-11-29Dadino Ronald CExpandable devices coated with a rapamycin composition
US20120302954A1 (en)2011-05-252012-11-29Zhao Jonathon ZExpandable devices coated with a paclitaxel composition
US9956385B2 (en)2012-06-282018-05-01The Spectranetics CorporationPost-processing of a medical device to control morphology and mechanical properties
KR20180058759A (en)2015-09-252018-06-01제트와이 테라퓨틱스 인코포레이티드 Pharmaceutical preparations based on microparticles comprising a polysaccharide-vitamin conjugate
CN110862410A (en)*2018-08-272020-03-06深圳福山生物科技有限公司Trifluoromethyl selenium compound and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4534899A (en)*1981-07-201985-08-13Lipid Specialties, Inc.Synthetic phospholipid compounds
US4942184A (en)*1988-03-071990-07-17The United States Of America As Represented By The Department Of Health And Human ServicesWater soluble, antineoplastic derivatives of taxol
US5059699A (en)*1990-08-281991-10-22Virginia Tech Intellectual Properties, Inc.Water soluble derivatives of taxol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU730244B2 (en)*1996-08-202001-03-01Enzon, Inc.High molecular weight polymer-based prodrugs

Also Published As

Publication numberPublication date
WO1994020089A1 (en)1994-09-15

Similar Documents

PublicationPublication DateTitle
AU6361294A (en)Taxol-based compositions with enhanced bioactivity
AU5794094A (en)Tricritical point composition
AU6303294A (en)Fuel composition
PL305070A1 (en)Silica-sodium-calcium glass compositions
AU2963192A (en)Fullerene-polymer compositions
AU6851694A (en)Polyester composition
AU7101094A (en)Factor ix - polymeric conjugates
AU6029594A (en)Factor viii - polymeric conjugates
AU1120495A (en)Bactericidal composition
AU6538594A (en)Fuel compositions
AU1013992A (en)Lice-repellant compositions
AU5936594A (en)Sunscreen compositions
AU7220794A (en)Detergent-package combination
AU7437094A (en)Disinfectant-detergent composition
AU1280095A (en)Bactericidal composition
AU6654594A (en)Moulding composition
AU5773994A (en)Cable-making compositions
AU672124B2 (en)Composition
AU1164892A (en)Compositions
AU1200495A (en)Ranitidine compositions
AU1516992A (en)Fuel composition
AU1119895A (en)External preparation
AU7992191A (en)Algicidally enhanced compositions
AU5512694A (en)Oral composition
RU2003257C1 (en)Phytotea composition

[8]ページ先頭

©2009-2025 Movatter.jp